India Ki Betiyan Ka Dhamaka! Family Businesses Ko Bana Rahi Hain Super Hit!

RESEARCH-REPORTS
Whalesbook Logo
AuthorVihaan Mehta|Published at:
India Ki Betiyan Ka Dhamaka! Family Businesses Ko Bana Rahi Hain Super Hit!
Overview

Full Power! India ki 10 young women successors ne toh kamaal hi kar diya hai. Woh bhi sab **50 saal** se kam umar mein, aur unki companies ki total value **₹8.16 lakh crore** se bhi zyada hai! Yeh sab Hurun ki latest report mein pata chala hai, jo bata rahi hai ki yeh leaders kaise sirf naam ki nahi, balki performance se apne business ko udaan de rahi hain.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Yeh Hai Nayi Generation Ki Power!

Chalo, yeh latest report jo ASK Private Wealth aur Hurun India ne nikali hai, uske hisaab se toh India ki betiyan business mein full dhamaal macha rahi hain. Report mein 50 aise next-gen leaders hain jinki companies ki total value ₹30.9 lakh crore ho gayi hai, jo India ke GDP ka 9.5% banta hai! Aur usmein se 10 ladkiyan toh 50 saal se choti hain, aur woh ₹8.16 lakh crore worth ki companies ko lead kar rahi hain. Mazaa toh yeh hai ki yeh sirf family business hone ki wajah se nahi, balki unke smart decisions aur achhe operations ki wajah se hai. Matlab, sirf paisa nahi, kaam bhi mast chal raha hai!

Kaun Hai Yeh Superwomen Aur Unki Companies?

Dekho, yeh leaders sirf paisa nahi bana rahi, balki smart capital use karke zabardast returns bhi laa rahi hain. Jaise:

  • Rama Kirloskar (Kirloskar Brothers): 17.7x growth multiple aur 26% ROCE.
  • Soumya Chava (Laurus Labs): Company ki value 16.2x badha di.
  • Avarna Jain (Saregama India): Digital se 14.8x multiple dilaya.
  • Priya Agarwal Hebbar (Hindustan Zinc): Industry mein sabse zyada 63% ROCE kamaya.

Sabse badi successor-led company hai Sun Pharmaceutical Industries, jiske peeche Vidhi Shanghvi hain, aur iski value ₹4.22 lakh crore se upar hai. Hindustan Zinc ₹2.50 lakh crore aur Laurus Labs lagbhag ₹60,000 crore worth ki hain. Ye sab dikhata hai ki kaise yeh leaders sirf assets jama karne ke bajaye value creation par focus kar rahi hain.

Valuation Ka Kya Scene Hai?

Abhi India ki economy bhi badh rahi hai (6.5% to 7.5% growth expected hai), aur Indian family businesses waise bhi kaafi strong hain. Lekin investors ko kuch companies ki valuations par nazar rakhni padegi. Jaise, Kirloskar Brothers ka P/E ratio 32x se 54.8x hai, aur Laurus Labs toh 72x se 105x tak jaa raha hai, jo kaafi high hai. Sun Pharma 33-37x, Hindustan Zinc 20-21x, Saregama India 34-48x aur Balrampur Chini Mills 21-25x ke aas paas hain. Growth toh hai, but investors ko future earnings aur competition ko bhi dekhna hoga.

Challenges Bhi Kam Nahi Hain!

Waise toh bahut achhi baat hai ki women leaders aage aa rahi hain, lekin India mein overall female leadership roles abhi bhi sirf 34% ke aas paas hain. Aur kai companies mein toh pichhle 5 saal mein women leaders ki representation kam bhi hui hai. Male directors ko female directors se 3.6 guna zyada milta hai, matlab pay gap bhi hai. Aur family businesses mein kabhi kabhi nepotism ya succession ke issues bhi ho sakte hain. Toh yeh leaders sirf achha kaam hi nahi, yeh challenges bhi face kar rahi hain.

Aage Kya?

Umeed hai India ki economy aage bhi strong rahegi, aur ye leaders apne businesses ko aur aage le jayengi. Sustainability aur good governance par focus badh raha hai, jo company ke liye achha hai. Jaise jaise women leaders ka influence badhega aur professional management badhega, waise waise India Inc. aur strong aur diversified hoga.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.